NCT00474409撤回4 期
A Multicenter, Placebo-Controlled, Double-Blind Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 发起方
- Eisai Inc.
- 试验地点
- 4
- 主要终点
- Changes in the European Evaluation of Vertigo (EEV) scale in 4 weeks.
研究概览
简要总结
The purpose of this study is to determine the efficacy and safety of Betahistine Mesilate in the treatment of patients with vertigo caused by Cerebral Infarction in posterior circulation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients that have a clinical diagnosis of posterior circulation infarction and vertigo occurring within 1 month after the infarction.
排除标准
- 未提供
结局指标
主要结局
Changes in the European Evaluation of Vertigo (EEV) scale in 4 weeks.
时间窗: 4 weeks
次要结局
- The duration of the vertigo symptom.
研究者
研究点 (4)
Loading locations...
相似试验
已完成
1 期
PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice DailyHealthyNCT01915901Biogen175
已完成
2 期
BTRX-246040 Study in Participants With Parkinson's Disease With Motor FluctuationsMotor DisorderParkinson DiseaseNCT03608371BlackThorn Therapeutics, Inc.24
已完成
2 期
A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride InjectionIndolent B-Cell Non-Hodgkin's LymphomasNCT04569838Chia Tai Tianqing Pharmaceutical Group Co., Ltd.91
已完成
2 期
The Effect of Betahistine on Body Weight in Obese SubjectsObesityNCT00409305OBEcure Ltd.280
已完成
4 期
The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood FlowGait or Balance Disorder ProblemsNCT01468285Abbott Products27